重寄生相关的专利数据

序号	专利名	申请号	申请日	公开（公告）号	公开（公告）日	发明人
61	3-carbamoyl-4-hydroxy-coumarins for combating parasitic heiminths	US35543	1987-04-03	US4766144A	1988-08-23	Nikolaus Muller; Eckart Kranz; Peter Andrews
3-carbamoyl-4-hydroxy-couramins for combating parasitic helminths of the formula ##STR1## in which R.sup.1 represents hydrogen, halogen, alkyl, NO.sub.2, CN or alkoxy,X represents O, S, SO or SO.sub.2R.sup.2 represents alkyl, halogenoalkyl, phenyl, naphthyl or pyridyl, which can optionally be substituted; or the radical -X-R.sup.2, together with the radical R.sup.3 can also form an alkylenedioxy (-O-alk-O), halogenoalkylenedioxy, oxyalkyleneoxyalkylene (-O-Alk-O-Alk-) or oxyhalogenoalkylene-oxyhalogenoalkylene bridge; andR.sup.3 and R.sup.4 independently of one another represent hydrogen, halogen, CN, OH, NO.sub.2, amino, mono- or dialklylamino, alkyl, halogenoalkyl, aralkyl or aryl, which can optionally be substituted,can be used for combating parasitic helminths.
62	LCD wherein opening in source electrode overlaps gate electrode to compensate variations in parasitic capacitance	US09329559	1999-06-10	US06310668B1	2001-10-30	Tooru Ukita
In a liquid crystal display device, a TFT is formed on a first transparent insulation substrate and includes: a semiconductor layer formed adjacent to a gate insulation film; a drain and a source electrode both formed in opposite ends of the semiconductor layer; and, a gate electrode formed in the gate insulation film so as to be disposed in a partially overlapping relationship with both the drain and the source electrode. The source electrode has a source notch portion which satisfies a predetermined equation to compensate for variations in parasitic capacitance appearing between the source and the gate electrode. The device prevents both its responsivity and its aperture ratio from deteriorating and also prevents its leakage current from increasing. The device is free from any possible restrictions caused by a specific construction of the TFT used in the device.
63	VERFAHREN ZUR REKONSTRUKTION DER INNEREN STRUKTUR EINES PROBENKÖRPERS MITTELS REFLEXIONS- UND STREUSIGNALEN	EP11718654.4	2011-04-07	EP2539870B1	2014-08-06	STOTZKA, Rainer; RUITER, Nicole

64	VERFAHREN ZUR REKONSTRUKTION DER INNEREN STRUKTUR EINES PROBENKÖRPERS MITTELS REFLEXIONS- UND STREUSIGNALEN	EP11718654.4	2011-04-07	EP2539870A2	2013-01-02	STOTZKA, Rainer; RUITER,Nicole
One aspect of the invention relates to a method for reconstructing the spatial distribution of a reflection coefficient for waves in a sample body, comprising the following steps: parameterizing the sample body by means of N volume elements; determining M different measurement configurations of an emitting device and an associated receiving device; defining the number T of measurement points; setting up M path matrices G ^[1], wherein the possible paths of reflected or scattered waves are encoded in the i-th path matrix; registering M series of measurements, wherein an excitation signal a ^[i] is fed to the emitting device in the i-th series of measurements, and the associated receiving device (5) registers a series of measurements x ^[i]; calculating a predictive differential vector Δ x = x- G- s ^[n], which contains the difference between the elements of the M registered series of measurements x ^[i] and the predictable series of measurements G ^[i] _tj-s ^[n] _j; minimizing a norm of the predictive differential vector \|\| Δ x \|\|; and providing the reflection coefficients s ^[n]. The invention also relates to an apparatus for carrying out the method.
65	Method for reworkable packaging of high speed, low electrical parasitic power electronics modules through gate drive integration	US14100288	2013-12-09	US09407251B1	2016-08-02	Brandon Passmore; Zach Cole; Bret Whitaker; Adam Barkley; Ty McNutt; Alexander Lostetter
A multichip power module directly connecting the busboard to a printed-circuit board that is attached to the power substrate enabling extremely low loop inductance for extreme environments such as high temperature operation. Wire bond interconnections are taught from the power die directly to the busboard further enabling enable low parasitic interconnections. Integration of on-board high frequency bus capacitors provide extremely low loop inductance. An extreme environment gate driver board allows close physical proximity of gate driver and power stage to reduce overall volume and reduce impedance in the control circuit. Parallel spring-loaded pin gate driver PCB connections allows a reliable and reworkable power module to gate driver interconnections.
66	Recombinant asparaginyl-tRNA synthetase from the human filarial parasite, brugia malayi	US441534	1995-05-15	US5561054A	1996-10-01	Michael A. Kron; Reuben Leberman
Recombinant asparaginyl tRNA synthetase from human filarial parasite Brugia malayi. The enzyme is used in an assay for inhibitors of the synthetase and can be used as an antigen for producing antibody inhibitors of the disease, either monoclonal or polyclonal. The antibodies can be used to detect the synthetase and related enzymes. In particular, the synthetase can be used to produce an antibody to be used for detecting filarial nematodes. The synthetase can be used to produce adenylated nucleosides.
67	Recombinant asparaginyl-tRNA synthetase from the human filarial parasite, Brugia malayi	US629752	1996-04-09	US5721116A	1998-02-24	Michael A. Kron; Reuben Leberman
Recombinant asparaginyl tRNA synthetase from human filarial parasite Brugia malayi. The enzyme is used in an assay for inhibitors of the synthetase and can be used as an antigen for producing antibody inhibitors of the disease, either monoclonal or polyclonal. The antibodies can be used to detect the synthetase and related enzymes. In particular, the synthetase can be used to produce an antibody to be used for detecting filarial nematodes. The synthetase can be used to produce adenylated nucleosides.
68	AUXOTROPHIC, RECOMBINANT BCG STRAIN PASTEUR AND USE THEREOF FOR COMBATING HUMAN INFECTIONS CAUSED BY PARASITES	EP10750256.9	2010-03-10	EP2407545A1	2012-01-18	TENDLER, Miriam; VILAR, Mônica Magno; ARMÔA, Geraldo Rodrigues Garcia; MCINTOSH, Douglas; SIMPSON, Andrew, J., G.
The present invention relates to a vaccinal strain of recombinant BCG Mycobacterium bovis expressing the Schistossoma mansoni Sm14 protein (BCG Pasteur ΔleuD/pΔK410-hsp60-Sm14). The vaccinal strain of the present invention is employed in the control of infections caused by parasites, specially the Schistossoma mansoni.* The vaccinal strain is a an auxotrophic strain to leucine amino acid derived from the BCG Pasteur sub-strain complemented to leucine after genetic transformation with the construct pΔK410-hsp60-Sm14. The efficacy of the BCG Pasteur ΔleuD/pΔK410-hsp60-Sm14 strain in the control of the Schistossoma mansoni infection based on the recombinant Sm14 antigen in vivo is showed in the present invention.
69	AUXOTROPHIC, RECOMBINANT BCG STRAIN PASTEUR AND USE THEREOF FOR COMBATING HUMAN INFECTIONS CAUSED BY PARASITES	EP10750256.9	2010-03-10	EP2407545B1	2016-07-06	TENDLER, Miriam; VILAR, Mônica Magno; ARMÔA, Geraldo Rodrigues Garcia; MCINTOSH, Douglas; SIMPSON, Andrew, J., G.
The present invention relates to a vaccinal strain of recombinant BCG Mycobacterium bovis expressing the Schistossoma mansoni Sm14 protein (BCG Pasteur ”leuD/p”K410-hsp60-Sm14). The vaccinal strain of the present invention is employed in the control of infections caused by parasites, specially the Schistossoma mansoni. The vaccinal strain is a an auxotrophic strain to leucine amino acid derived from the BCG Pasteur sub-strain complemented to leucine after genetic transformation with the construct p”K410-hsp60-Sm14. The efficacy of the BCG Pasteur ”leuD/p”K410-hsp60*-Sm14 strain in the control of the Schistossoma mansoni infection based on the recombinant Sm14 antigen in vivo is showed in the present invention.
70	AUXOTROPHIC, RECOMBINANT BCG STRAIN PASTEUR AND USE THEREOF FOR COMBATING HUMAN INFECTIONS CAUSED BY PARASITES	EP10750256	2010-03-10	EP2407545A4	2013-06-19	TENDLER MIRIAM; VILAR MONICA MAGNO; ARMOA GERALDO RODRIGUES GARCIA; MCINTOSH DOUGLAS; SIMPSON ANDREW J G
The present invention relates to a vaccinal strain of recombinant BCG Mycobacterium bovis expressing the Schistossoma mansoni Sm14 protein (BCG Pasteur ”leuD/p”K410-hsp60-Sm14). The vaccinal strain of the present invention is employed in the control of infections caused by parasites, specially the Schistossoma mansoni. The vaccinal strain is a an auxotrophic strain to leucine amino acid derived from the BCG Pasteur sub-strain complemented to leucine after genetic transformation with the construct p”K410-hsp60-Sm14. The efficacy of the BCG Pasteur ”leuD/p”K410-hsp60*-Sm14 strain in the control of the Schistossoma mansoni infection based on the recombinant Sm14 antigen in vivo is showed in the present invention.
71	Crossbar device with reduced parasitic capacitive loading and usage of crossbar devices in reconfigurable circuits	US10043964	2002-01-10	US06874136B2	2005-03-29	Frederic Reblewski; Olivier Lepape
A crossbar device includes a first set of input lines and a second set of output lines. A plurality of chains of pass transistors are provided to selectively couple the input lines to the output lines in a reduced parasitic capacitive loading manner. Further, memory elements and decoder logic are provided to facilitate control of the selective coupling. Additionally, a low power application of multiple crossbar devices to a reconfigurable circuit block is improved by having each memory element of a crossbar device be provided with a supply voltage higher by a Vth to maintain the input voltage of corresponding output buffers at Vdd. Further, an application of multiple crossbar devices to a reconfigurable circuit block is improved by coupling a control circuitry via a control line to all output buffers of the interconnected crossbar devices to force the output buffers to a known state at power-on.
72	Crossbar device with reduced parasitic capacitive loading and usage of crossbar devices in reconfigurable circuits	US10043964	2002-01-10	US20030131331A1	2003-07-10	Frederic Reblewski; Olivier Lepape
A crossbar device includes a first set of input lines and a second set of output lines. A plurality of chains of pass transistors are provided to selectively couple the input lines to the output lines in a reduced parasitic capacitive loading manner. Further, memory elements and decoder logic are provided to facilitate control of the selective coupling. Additionally, a low power application of multiple crossbar devices to a reconfigurable circuit block is improved by having each memory element of a crossbar device be provided with a supply voltage higher by a Vth to maintain the input voltage of corresponding output buffers at Vdd,. Further, an application of multiple crossbar devices to a reconfigurable circuit block is improved by coupling a control circuitry via a control line to all output buffers of the interconnected crossbar devices to force the output buffers to a known state at power-on.
73	Method of using recombinant asparaginyl-tRNA synthetase to detect human filarial parasite, Brugia malayi	US628103	1996-04-09	US5695962A	1997-12-09	Michael A. Kron; Reuben Leberman
Recombinant asparaginyl tRNA synthetase from human filarial parasite Brugia malayi. The enzyme is used in an assay for inhibitors of the synthetase and can be used as an antigen for producing antibody inhibitors of the disease, either monoclonal or polyclonal. The antibodies can be used to detect the synthetase and related enzymes. In particular, the synthetase can be used to produce an antibody to be used for detecting filarial nematodes. The synthetase can be used to produce adenylated nucleosides.
74	Method of providing systemic protection from bloodsucking insects and other parasites using encapsulated additives in resealed erythrocytes	US332905	1981-12-21	US4389209A	1983-06-21	John R. DeLoach; Robert L. Harris; Mayery Richard T.; Garret M. Ihler
A process for encapsulating additives in resealed erythrocytes from the blood of certain mammals. The invention provides a method of preparing material in substantial quantities, to be employed as vaccine which, when reinjected into these mammals, provides a systemic protection against bloodsucking insects or other parasites.
75	Integrated circuit having an interlevel interconnect coupled to a source/drain region(s) with source/drain region(s) boundary overlap and reduced parasitic capacitance	US73639	1998-05-06	US6146978A	2000-11-14	Mark W. Michael; Robert Dawson; H. Jim Fulford, Jr.; Mark I. Gardner; Frederick N. Hause; Bradley T. Moore; Derick J. Wristers
An interlevel interconnect is formed in a window opened through an isolation layer and through an etch barrier to expose an electrode surface and an adjacent isolation barrier. The interlevel interconnect may be disposed on substantially all of a portion of the underlying electrode such as an insulated gate field effect transistor (IGFET) source/drain region surface. The etch barrier provides controlled etching to allow for overlap of the interlevel interconnect onto the isolation barrier without increased parasitic capacitance relative to conventional contact misalignments. Furthermore, allaying concerns of overlapping allows for increased utilization of source/drain region surface area by the interlevel interconnect. Furthermore, the etch barrier allows the interlevel interconnect to strap electrodes of a plurality of circuit devices while exhibiting nominal if any substrate to interlevel interconnect leakage currents.
76	Assay for detection of filariasis using recombinant asparaginyl-tRNA synthetase from the human filrial parasite, Brugia malayi	US802991	1997-02-21	US5846771A	1998-12-08	Michael A. Kron; Reuben Leberman
Recombinant asparaginyl tRNA synthetase from human filarial parasite Brugia malayi. The enzyme is used in an assay for inhibitors of the synthetase and can be used as an antigen for producing antibody inhibitors of the disease, either monoclonal or polyclonal. The antibodies can be used to detect the synthetase and related enzymes. In particular, the synthetase can be used to produce an antibody to be used for detecting filarial nematodes. The synthetase can be used to produce adenylated nucleosides.
77	FUSION PROTEIN OF PARAMYXOVIRUS, METHOD OF PRODUCTION USING RECOMBINANT BACULOVIRUS EXPRESSION VECTOR, VACCINE COMPRISING SUCH PROTEIN AND USE THEREOF	EP89910526	1989-08-29	EP0433371A4	1991-10-30	COMPANS, RICHARD, W.; RAY, RANJIT

78	Pharmaceutical composition to prevent and treat epithelial wounds, immunomodulating pharmaceutical composition, pharmaceutical composition, insecticide, insecticide composition insecticide use of lectin KM+ to treat cicatrizations, use of lectin KM+ to prepare immunomodulating medicament, use of lectin KM+ to prepare anti-bacterial medicament, use lectin KM+ to prpare anti-viral medicament, use of lectin KM+ to prepare anti-parasite medicament, use of lectin KM+ to prepare anti-fungal medicament, use of lectin KM+ to prepare anti-parasite medicament expression method, DNA vector, recombinant	US11271509	2005-11-10	US20070105754A1	2007-05-10	Luis Pinto Da Silva; Ademilson Castelo; Maria De Souza Goldman; Maria Roque Antunes Barreira; Ricardo De Oliveira; Marcelo Baruffi; Jeanne Blanco Machado
The invention deals with a pharmaceutical composition comprising lectin KM+ to prevent and heal epithelial wounds. The invention also comprises the use of lectin KM+, obtained from the plant (Artocarpus integrifolia) or recombinant (expression heterologue) to prepare medicaments.
79	液晶显示面板及其像素结构	CN200810133913.5	2008-07-15	CN100573287C	2009-12-23	萧嘉强; 罗诚; 郑景升; 胡至仁
一种液晶显示面板及其像素结构，其中一种液晶显示面板的像素结构，包括第一透明基板、第一数据线、第二数据线、透明电极，以及补偿导体图案。在显示区内，透明电极的第一侧与第一数据线部分重叠而形成第一寄生电容，透明电极的第二侧与第二数据线部分重叠而形成第二寄生电容，且第一寄生电容大于第二寄生电容；在非显示区内，透明电极的第一侧与第一数据线部分重叠而形成第三寄生电容，透明电极的第二侧与补偿导体图案重叠而形成第四寄电容，且第一寄生电容与第三寄生电容的总寄生电容与第二寄生电容与第四寄生电容的总寄生电容实质上相等。本发明可提供一种液晶显示面板的像素结构，以解决串音效应并提升开口率。
80	液晶显示面板及其像素结构	CN200810133913.5	2008-07-15	CN101308296A	2008-11-19	萧嘉强; 罗诚; 郑景升; 胡至仁
一种液晶显示面板及其像素结构，其中一种液晶显示面板的像素结构，包括第一透明基板、第一数据线、第二数据线、透明电极，以及补偿导体图案。在显示区内，透明电极的第一侧与第一数据线部分重叠而形成第一寄生电容，透明电极的第二侧与第二数据线部分重叠而形成第二寄生电容，且第一寄生电容大于第二寄生电容；在非显示区内，透明电极的第一侧与第一数据线部分重叠而形成第三寄生电容，透明电极的第二侧与补偿导体图案重叠而形成第四寄电容，且第一寄生电容与第三寄生电容的总寄生电容与第二寄生电容与第四寄生电容的总寄生电容实质上相等。本发明可提供一种液晶显示面板的像素结构，以解决串音效应并提升开口率。

1 2 3 4 5 6 7 8 9 10

IPRDB

热门服务

关于我们

友情链接

联系方式